Premium
Implication of the INK4a/ARF Locus in Gastroenteropancreatic Neuroendocrine Tumorigenesis
Author(s) -
SIMON BABETTE,
LUBOMIERSKI NIKOLAUS
Publication year - 2004
Publication title -
annals of the new york academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.712
H-Index - 248
eISSN - 1749-6632
pISSN - 0077-8923
DOI - 10.1196/annals.1294.033
Subject(s) - suppressor , gene silencing , carcinogenesis , cancer research , tumor suppressor gene , methylation , locus (genetics) , biology , medicine , oncology , gene , genetics
A bstract : The INK4a/ARF locus on chromosome 9p21 is one of the important defenses against tumor development and engages both the Rb and the p53 tumor suppressor pathways through its capacity to encode two distinct proteins, p16 INK4a and p14 ARF . Despite controversial reports, the body of present data suggests that tumor suppressors p16 INK4a and p14 ARF are targets of in‐activation in GEP‐NETs. Moreover, tumor type‐specific aberrant p16 INK4a silencing appears to be associated with advanced tumor stage and may function as a predictor of patients' outcome after surgical resection. Since conventional histological and biochemical assessment are limited with respect to predicting GEP‐NET behavior or outcome, methylation profiles including INK4a/ARF might offer a tool to refine future diagnosis and therapeutic management of GEP‐NET patients.